**Core Concept**
In patients with renal failure, the choice of muscle relaxant is critical due to the potential for accumulation of metabolites or the drug itself, leading to prolonged neuromuscular blockade. The ideal muscle relaxant in this setting would have a short duration of action, minimal active metabolites, and a rapid elimination profile.

**Why the Correct Answer is Right**
Vecuronium is a non-depolarizing muscle relaxant that is primarily eliminated by the liver and has a short duration of action. Its active metabolite, 3-desacetylvecuronium, has a minimal effect on neuromuscular blockade. Vecuronium is also less dependent on renal elimination compared to other non-depolarizing muscle relaxants like pancuronium. This makes vecuronium a suitable choice in patients with renal failure.

**Why Each Wrong Option is Incorrect**
**Option A:** Atracurium is a non-depolarizing muscle relaxant that undergoes Hofmann elimination, a process that is independent of liver or kidney function. However, its active metabolite, laudanosine, can cause central nervous system side effects.

**Option B:** Pancuronium is a non-depolarizing muscle relaxant that is primarily eliminated by the kidneys. Its long duration of action and active metabolites make it a less suitable choice in patients with renal failure.

**Option C:** Succinylcholine is a depolarizing muscle relaxant that is primarily metabolized by plasma cholinesterase. While it has a short duration of action, its potential for causing hyperkalemia in patients with renal failure limits its use.

**Option D:** Mivacurium is a non-depolarizing muscle relaxant that is primarily metabolized by plasma cholinesterase. However, its short duration of action and rapid metabolism make it less suitable for prolonged muscle relaxation in patients with renal failure.

**Clinical Pearl / High-Yield Fact**
In patients with renal failure, it is essential to choose a muscle relaxant with a short duration of action and minimal active metabolites to avoid prolonged neuromuscular blockade. Vecuronium is a suitable choice due to its rapid elimination profile and minimal dependence on renal function.

**Correct Answer: C. Succinylcholine is a depolarizing muscle relaxant that is primarily metabolized by plasma cholinesterase. While it has a short duration of action, its potential for causing hyperkalemia in patients with renal failure limits its use.**